CON AntiTNFs should be used before Vedolizumab for moderate to severe IBD

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=6FnIsPALcdM

Dedicated to the interests of the entire community of patients with inflammatory bowel disease (IBD), and designed to meet the educational needs of all healthcare professionals who treat and manage patients with IBD, 2014 Advances in Inflammatory Bowel Diseases, Crohn’s Colitis Foundation’s Clinical and Research Conference is the foremost event for investigators and healthcare professionals to come together, share their knowledge and experience, and learn about the latest advances and new insights for personalized care of patients with IBD. This webcast was designed to meet the educational needs of all healthcare professionals who treat and manage patients with inflammatory bowel diseases, with a focus on information shared among clinicians and researchers. Participants will gain insight from expert faculty on breakthroughs in cutting-edge research and in advancements in IBD patient care. • In this video, Dr. Asher A. Kornbluth presents: CON: Anti-TNFs should be used before Vedolizumab for moderate to severe IBD. • Earn accreditation for this activity at the following location: • http://elc.imedex.com/elc/activity-se... • © 2015 Imedex, LLC.

#############################

New on site